EPCS IX: EuroPainClinicsStudy IX

Sponsor
Europainclinics z.ú. (Other)
Overall Status
Completed
CT.gov ID
NCT04686903
Collaborator
Brno University Hospital (Other), Slovak Academy of Sciences (Other), Pavol Jozef Safarik University (Other)
150
1
3
24
6.3

Study Details

Study Description

Brief Summary

Prospective comparison between epiduroscopy procedure, Racz catheter procedure and caudal epidural block in patients with FBSS

Condition or Disease Intervention/Treatment Phase
  • Procedure: Epiduroscopy treatment
  • Procedure: Racz catheter epidural procedure
  • Procedure: Caudal epidural block
N/A

Detailed Description

  1. Epiduroscopy is an advanced proven diagnostic and therapeutic method for chronic radicular pain after spinal surgery. Moreover, this method is frequently used in patients with chronic low back pain conditions without previous spine surgery also known as "virgin back". Epiduroscopy allows by optical fiber technology and skiascopy imaging the exact examination of the epidural space and subsequently mechanical lysis (with advanced interventional options by laser, radiofrequency, balloon techniques etc.) and/or drug administration to the target point.

  2. The Racz catheter procedure is based on epidural neurolysis. It is used to release some of the adhesions or scar tissue which surround entrapped nerves in the epidural space of the spine. This state could be caused by chronic inflammatory adhesions or by healing mechanisms after spine surgery - scars. Mechanical liberation of epidural space further allows better administration and targeting of drugs as corticoids or hyaluronidase. This technique is performed under fluoroscopy imaging. Suitable epidurogram and skiascopy confirm appropriate catheter position during procedure.

  3. The caudal epidural block involves placing a needle through the sacral hiatus to deliver medications into the epidural space. This approach to the epidural space is popular in managing a wide variety of chronic pain conditions in adults, especially chronic low back pain syndromes. Fluoroscopy is considered as a gold standard of needle guidance during procedures in which caudal epidural injections are performed.

Study Design

Study Type:
Interventional
Actual Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
3 paralel groups: Group A Epiduroscopy in patients with FBSS (50 patients) Group B Racz catheter epidural procedure in patients with FBSS (50 patients) Group C Caudal epidural block in patients with FBSS (50 patients)3 paralel groups: Group A Epiduroscopy in patients with FBSS (50 patients) Group B Racz catheter epidural procedure in patients with FBSS (50 patients) Group C Caudal epidural block in patients with FBSS (50 patients)
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Comparison Between Epiduroscopy Procedure, Racz Catheter Procedure and Caudal Epidural Block in Patients With FBSS
Actual Study Start Date :
Jan 1, 2020
Actual Primary Completion Date :
Aug 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Epiduroscopy

Epiduroscopy in patients with FBSS

Procedure: Epiduroscopy treatment
Device Epiduroscop, procedure mecahnical lysis, laser, radiofrequency + drug administration into the epidural space (corticosteroid methylprednisolone acetate 80mg and solution of hyaluronidase 150 I.U. in 10mL of saline) Follow-up: before procedure, 6 months and 12 months after procedure

Experimental: Racz catheter epidural procedure

Racz catheter epidural procedure in patients with FBSS

Procedure: Racz catheter epidural procedure
Device Racz catheter, two procedures during clinical trial observation First procedure after enrolment into the study mechanical lysis and drug administration into the epidural space (corticosteroid methylprednisolone acetate 80mg and solution of hyaluronidase 150 I.U. in 10mL of saline) Second procedure after 6 months mechanical lysis + drug administration into the epidural space (corticosteroid methylprednisolone acetate 80mg and solution of hyaluronidase 150 I.U. in 10mL of saline)

Experimental: Caudal epidural block

Caudal epidural block treatment of FBSS

Procedure: Caudal epidural block
Technique Caudal epidural block Three procedures during clinical trial observation : First procedure after enrolment into the study drug administration into the epidural space (corticosteroid methylprednisolone acetate 80mg and solution of hyaluronidase 150 I.U. in 10mL of saline) Second procedure after 4 months drug administration into the epidural space (corticosteroid methylprednisolone acetate 80mg) Third procedure after 8 months drug administration into the epidural space (corticosteroid methylprednisolone acetate 80mg)

Outcome Measures

Primary Outcome Measures

  1. Change from baseline EuroQoL-5 dimension (EQ-5D) value 6m [6 months follow-up]

    EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression

  2. Change from baseline EuroQoL-5 dimension (EQ-5D) value 12m [12 months follow-up]

    EQ-5D-5L self-care, usual activities, pain/discomfort and anxiety/depression

  3. Change from baseline Visual Analog Pain Scale (VAS) of back pain 6m [6 months follow-up]

    VAS 10 point measurement

  4. Change from baseline Visual Analog Pain Scale (VAS) of back pain 12 m [12 months follow-up]

    VAS 10 point measurement

  5. Oswestry disability index (ODI) 6m [6 months follow-up]

    he ODI self-administered questionnaire measuring 0-100 scale function.'' The questionnaire comprises 10 items, each with 6 levels of response. Each item is scored from 0 to 5, and the total summation is converted to a 0-100 scale. The ODI scores range from 0 to 100, with higher scores indicating severe symptoms.

  6. Oswestry disability index (ODI) 12m [12 months follow-up]

    he ODI self-administered questionnaire measuring 0-100 scale function.'' The questionnaire comprises 10 items, each with 6 levels of response. Each item is scored from 0 to 5, and the total summation is converted to a 0-100 scale. The ODI scores range from 0 to 100, with higher scores indicating severe symptoms.

Secondary Outcome Measures

  1. Before procedure drug usage [before procedure]

    drug usage

  2. Postprocedural drug usage [before procedure]

    drug usage

  3. Radiation exposure [12 months follow-up]

    Dose of radiation exposure

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients aged between 20 and 80

  • patients with FBSS (at least 1 - up to 2 lumbar laminectomies) who has radiating pain (VAS >=5) on lower extremities

  • those who (only if a signature was obtainable), or whose legal guardian, fully understood the clinical trial details and signed the informed consent form

Exclusion Criteria:
  • more than 2 lumbar laminectomies

  • patients without previous spine surgery

  • patients with a history of other spinal diseases (compression fracture, spondylitis, tumor)

  • women with a positive pregnancy test before the trial or who planned to become pregnant within the following 3 years

  • other patients viewed as inappropriate by the staff

  • disagreement with participation in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 EuroPainClinics Bardejov Slovakia 085 01

Sponsors and Collaborators

  • Europainclinics z.ú.
  • Brno University Hospital
  • Slovak Academy of Sciences
  • Pavol Jozef Safarik University

Investigators

  • Study Chair: Miroslav Burianek, MD MBA, Europainclinics z.ú.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Europainclinics z.ú.
ClinicalTrials.gov Identifier:
NCT04686903
Other Study ID Numbers:
  • 03595/2020/OZ-30
First Posted:
Dec 29, 2020
Last Update Posted:
Jan 3, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 3, 2022